U.S. Epilepsy Drugs Market Trends 2034: Advancements in Antiepileptic Drug Development and Personalized Treatment Approaches
The United States leads the Epilepsy Drugs Market due to its large patient population, substantial healthcare spending, and strong presence of pharmaceutical manufacturers. Rising adoption of next-generation antiepileptic drugs, growing investments in neurological research, and increasing focus on improving seizure management are further contributing to market expansion in the country....
0 Comments 0 Shares 7 Views 0 Reviews